Phenytoin
DrugBank ID: DB00252
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 3 |
| DL Only | 47 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| trigeminal nerve neoplasm | 0.9999 | DL |
| visual epilepsy | 0.9999 | DL |
| audiogenic seizures | 0.9998 | DL |
| eating seizures | 0.9998 | DL |
| micturation-induced seizures | 0.9998 | DL |
| orgasm-induced seizures | 0.9998 | DL |
| startle epilepsy | 0.9998 | DL |
| thinking seizures | 0.9998 | DL |
| reading seizures | 0.9997 | DL |
| trigeminal neuralgia | 0.9997 | DL |
| beta-ketothiolase deficiency | 0.9995 | DL |
| Rett syndrome, congenital variant | 0.9994 | DL |
| 14q12 microdeletion syndrome | 0.9993 | DL |
| partial epilepsy | 0.9993 | DL |
| status epilepticus | 0.9992 | KG+DL |
| guanidinoacetate methyltransferase deficiency | 0.9985 | DL |
| partial motor epilepsy | 0.9979 | DL |
| epilepsy with generalized tonic-clonic seizures | 0.9979 | DL |
| adolescent/adult onset autosomal dominant epilepsy with auditory features | 0.9976 | DL |
| restless legs syndrome | 0.9973 | DL |
| epilepsy | 0.9956 | DL |
| myoclonic-atonic epilepsy | 0.9897 | DL |
| Lennox-Gastaut syndrome | 0.9893 | KG+DL |
| facial neuralgia | 0.9890 | DL |
| combined hyperactive dysfunction syndrome of the cranial nerves | 0.9878 | DL |
| atypical childhood epilepsy with centrotemporal spikes | 0.9846 | DL |
| cryptogenic late-onset epileptic spasms | 0.9846 | DL |
| photosensitive occipital lobe epilepsy | 0.9846 | DL |
| febrile infection-related epilepsy syndrome | 0.9842 | DL |
| perioral myoclonia with absences | 0.9827 | DL |
| electroclinical syndrome | 0.9787 | DL |
| cutis verticis gyrata | 0.9735 | KG+DL |
| myofascial pain syndrome | 0.9676 | DL |
| early onset absence epilepsy | 0.9430 | DL |
| childhood onset epileptic encephalopathy | 0.9419 | DL |
| benign occipital epilepsy | 0.9392 | DL |
| glossopharyngeal motor neuropathy | 0.9304 | DL |
| early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation | 0.9286 | DL |
| acute encephalopathy with biphasic seizures and late reduced diffusion | 0.9235 | DL |
| familial hemiplegic migraine | 0.9152 | DL |
| gaze palsy, familial horizontal, with progressive scoliosis | 0.9145 | DL |
| epilepsy, nocturnal frontal lobe | 0.9140 | DL |
| trichotillomania | 0.9108 | DL |
| idiopathic neonatal atrial flutter | 0.9105 | DL |
| vagus nerve disease | 0.9004 | DL |
| glossopharyngeal nerve paralysis | 0.9002 | DL |
| acne (disease) | 0.8991 | DL |
| asperger syndrome, susceptibility to | 0.8985 | DL |
| glossopharyngeal nerve neoplasm | 0.8979 | DL |
| EAST syndrome | 0.8902 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.